Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Chikashi Seto"'
Publikováno v:
Urology Case Reports, Vol 4, Iss C, Pp 33-35 (2016)
A 66-year-old male, who had received renal transplantation 10 years before, was admitted to our hospital with urinary retention. The prostate volume was 169.2 ml. Furthermore, grade 5 vesicoureteral reflux (VUR) was shown in the cystography. Holmium
Externí odkaz:
https://doaj.org/article/bc63d56cd841427c8c183649a65c231d
Autor:
Shohei Kawaguchi, Takahiro Nohara, Takashi Shima, Satoko Matsuyama, Chikako Nose, Junya Yamahana, Yoshifumi Kadono, Chikashi Seto, Masahiko Kawabata, Atsushi Mizokami
Publikováno v:
Case Reports in Transplantation, Vol 2016 (2016)
Retroperitoneal lymphocele is a common complication of renal transplantation. Here, we report the case of a 67-year-old woman with massive ascites after fenestration surgery for a lymphocele that developed following renal transplantation. She had bee
Externí odkaz:
https://doaj.org/article/3a9d03b5acfa4699a61e474dfeb169b4
Autor:
Satoko Matsuyama, Takahiro Nohara, Shohei Kawaguchi, Chikashi Seto, Yuko Nakanishi, Akio Uchiyama, Shin Ishizawa
Publikováno v:
Case Reports in Urology, Vol 2015 (2015)
Here, we report a case of stromal tumor of uncertain malignant potential (STUMP) that was difficult to diagnose. A 53-year-old male was found to have a hard nodule on digital rectal examination; magnetic resonance imaging revealed a large nodule on t
Externí odkaz:
https://doaj.org/article/533fa8c4d1e949898e09f59cf1ecfc85
Autor:
Chikashi Seto, Taiki Kamijima, Akinobu Takano, Satoshi Yotsuyanagi, Shuhei Aoyama, Rie Fukuda, Hideki Asahi, Kazuyoshi Shigehara, Yoshifumi Kadono, Ryunosuke Nakagawa, Takahiro Nohara, Atsushi Mizokami, Tohru Miyagi, Kouji Izumi, Shohei Kawaguchi
Publikováno v:
Anticancer Research. 41:1599-1606
BACKGROUND/AIM To investigate the blood markers for predicting pembrolizumab efficacy in advanced urothelial carcinoma (UC). PATIENTS AND METHODS This study included 91 advanced UC patients. The relationship between prognosis and markers from periphe
Autor:
Yoshifumi, Kadono, Shohei, Kawaguchi, Takahiro, Nohara, Kazuyoshi, Shigehara, Kouji, Izumi, Taiki, Kamijima, Chikashi, Seto, Akinobu, Takano, Satoshi, Yotsuyanagi, Ryunosuke, Nakagawa, Tohru, Miyagi, Shuhei, Aoyama, Hideki, Asahi, Rie, Fukuda, Atsushi, Mizokami
Publikováno v:
Urology journal. 19(3)
Pembrolizumab is currently considered the standard second-line treatment for advanced urothelial carcinoma (UC). This study aimed to investigate the efficacy and safety of pembrolizumab in patients with advanced UC in real-world data, which is not we
Autor:
Takahiro Nohara, Chikashi Seto, Yoshifumi Kadono, Atsushi Mizokami, Kazuyoshi Shigehara, Kouji Izumi, Takashi Shima
Publikováno v:
Videourology. 35
Autor:
Suguru Kadomoto, Yoshifumi Kadono, Kazuyoshi Shigehara, Atsushi Mizokami, Masashi Iijima, Kouji Izumi, Takashi Shima, Chikashi Seto, Hiroaki Iwamoto, Shohei Kawaguchi, Takahiro Nohara, Hiroshi Yaegashi
Publikováno v:
Journal of robotic surgery. 16(3)
We performed test clamp procedure in robot-assisted partial nephrectomy (RAPN) to prevent massive bleeding during tumor resection and to omit dissection of non-feeding arteries around the tumor. We subsequently analyzed the safety and usefulness of t
Autor:
Yuta Takezawa, Kazuyoshi Shigehara, Chikashi Seto, Hiroaki Iwamoto, Kouji Izumi, Takashi Shima, Atsushi Mizokami, Takahiro Nohara, Kazuaki Machioka, Taiki Kamijima, Yoshifumi Kadono
Publikováno v:
In Vivo. 33:877-880
Background/Aim: A peripherally inserted central catheter (PICC) is recommended for the safe administration of anticancer agents. The effectiveness of synthetic polymer-coated and non-coated PICCs was compared. Patients and Methods: Patients with adva
Autor:
Tohru Miyagi, Taiki Kamijima, Takahiro Nohara, Kouji Izumi, Satoshi Yotsuyanagi, Atsushi Mizokami, Chikashi Seto, Hideki Asahi, Kazuyoshi Shigehara, Shohei Kawaguchi, Akinobu Takano, Yoshifumi Kadono, Ryunosuke Nakagawa, Shuhei Aoyama, Rie Fukuda
Background: Pembrolizumab is currently considered the standard second-line treatment for advanced urothelial carcinoma (UC). This study aimed to investigate the efficacy and safety of pembrolizumab in patients with advanced UC in real-world data, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dafc437221964223be93ba4c4ad6178c
https://doi.org/10.21203/rs.3.rs-81346/v1
https://doi.org/10.21203/rs.3.rs-81346/v1
Autor:
Isao Furuki, Kinuyo Takahashi, Masahiro Wakasugi, Chikashi Seto, Hiroshi Okudera, Tomonori Hasegawa, Shiro Takahara
Publikováno v:
Transplantation proceedings. 51(10)
Background Among Organisation for Economic Co-operation and Development countries, the number of cadaveric donors per population is the lowest in Japan. The present study investigated whether a continuing educational intervention for medical staff, s